Salarius Pharmaceuticals
SLRX
SLRX
14 hedge funds and large institutions have $104K invested in Salarius Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 1 closing their positions.
Holders
14
Holders Change
+5
Holders Change %
+55.56%
% of All Funds
0.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
3
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
HF
1
HRT Financial
New York
|
$28K |
| 2 |
CSS
2
Cubist Systematic Strategies
Stamford,
Connecticut
|
$15K |
| 3 |
3
Goldman Sachs
New York
|
$14.9K |
| 4 |
4
Barclays
London,
United Kingdom
|
$7K |
| 5 |
5
Citigroup
New York
|
$5.28K |
Top Sellers
| 1 |
1
UBS Group
Zurich,
Switzerland
|
$16.3K |
| 2 |
TSS
2
Two Sigma Securities
New York
|
$0 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
HF
1
HRT Financial
New York
| $28K | 31,676 | +31,676 | New |
|
|
2
UBS Group
Zurich,
Switzerland
| $16.3K | 18,138 | -15,674 | -46% |
|
|
CSS
3
Cubist Systematic Strategies
Stamford,
Connecticut
| $15K | 16,727 | +16,727 | New |
|
|
4
Goldman Sachs
New York
| $14.9K | 16,667 | +16,667 | New |
|
5
Geode Capital Management
Boston,
Massachusetts
| $13.9K | 15,560 | +4,057 | +35% |
|
|
6
Barclays
London,
United Kingdom
| $7K | 8,024 | +8,024 | New |
|
|
7
Citigroup
New York
| $5.28K | 5,889 | +5,889 | New |
|
|
TRCT
8
Tower Research Capital (TRC)
New York
| $3.28K | 3,663 | +334 | +10% |
|
9
Osaic Holdings
Scottsdale,
Arizona
| $297 | 162 | – | – |
|
|
MYIA
10
Mount Yale Investment Advisors
Denver,
Colorado
| $55 | 61 | +61 | New |
|
11
Bank of America
Charlotte,
North Carolina
| $16 | 18 | +6 | +50% |
|
12
Morgan Stanley
New York
| $6 | 7 | – | – |
|
13
BlackRock
New York
| $1 | 1 | – | – |
|
|
SS
14
SBI Securities
Tokyo,
Japan
| $1 | 1 | – | – |
|
|
TSS
15
Two Sigma Securities
New York
| – | – | -15,348 | Closed |
|